Attached files
file | filename |
---|---|
EX-21.1 - EXHIBIT 21.1 - IONIS PHARMACEUTICALS INC | exhibit21_1.htm |
EX-32.1 - EXHIBIT 32.1 - IONIS PHARMACEUTICALS INC | exhibit32_1.htm |
EX-31.1 - EXHIBIT 31.1 - IONIS PHARMACEUTICALS INC | exhibit31_1.htm |
EX-10.61 - EXHIBIT 10.61 - IONIS PHARMACEUTICALS INC | exhibit10_61.htm |
EX-10.59 - EXHIBIT 10.59 - IONIS PHARMACEUTICALS INC | exhibit10_59.htm |
EX-10.60 - EXHIBIT 10.60 - IONIS PHARMACEUTICALS INC | exhibit10_60.htm |
EXCEL - IDEA: XBRL DOCUMENT - IONIS PHARMACEUTICALS INC | Financial_Report.xls |
10-K - IONIS PHARMACEUTICALS INC | form10k.htm |
EX-31.2 - EXHIBIT 31.2 - IONIS PHARMACEUTICALS INC | exhibit31_2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 33-55790, 33-72124, 33-75068, 33-96138, 333-71911, 333-90811, 333-38844, 333-71116, 333-71176, 333-89066, 333-89626, 333-128156, 333-130639, 333-134380, 333-141447, 333-151076, 333-188407 and Form S-8 Nos. 33-42356, 33-42970, 33-51236, 33-54840, 33-58450, 33-75150, 33-90780, 333-05825, 333-55683, 333-40336, 333-59296, 333-91572, 333-106859, 333-116962, 333-125911, 333-133853, 333-142777, 333-151996, 333-160269, 333-168674, 333-176136, 333-184788, 333-190408) of Isis Pharmaceuticals, Inc. and in the related Prospectus of our reports dated February 27, 2015, with respect to the consolidated financial statements of Isis Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Isis Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
|
/s/ ERNST & YOUNG LLP
|
|
|
San Diego, California
|
|
February 27, 2015
|
|